Marangu Diana, Jowi Christine, Aswani Joyce, Wambani Sidika, Nduati Ruth
Department of Paediatrics and Child Health, University of Nairobi, Nairobi, Kenya.
Department of Paediatrics and Child Health, University of Nairobi, Nairobi, Kenya.
Int J Pediatr Otorhinolaryngol. 2014 Aug;78(8):1381-6. doi: 10.1016/j.ijporl.2014.06.002. Epub 2014 Jun 16.
Adenotonsillar hypertrophy is a common condition in childhood, whose serious complications of pulmonary hypertension and cor pulmonale are devastating but local prevalence is unknown. This study determined the prevalence and associated factors of pulmonary hypertension in children with adenoid or adenotonsillar hypertrophy at Kenyatta National Hospital, Kenya.
This was a cross sectional hospital based survey conducted among children below 12 years of age with clinical and radiological adenoid hypertrophy attending the ear, nose and throat (ENT) outpatient clinic and general pediatric wards. Doppler echocardiography was used to determine pulmonary hypertension defined as a mean pulmonary arterial pressure (mPAP) of ≥ 25 mm Hg using the Chemla equation. Children with mPAP of ≥ 25 mm Hg were compared to those with lower pressures and clinical and radiological factors associated with pulmonary hypertension determined using multivariate logistic regression analysis.
Of the 123 eligible children in the study, 27 had pulmonary hypertension giving a prevalence of 21.9% (95% CI 14.64%-29.27%). Independent factors associated with pulmonary hypertension included nasal obstruction (OR=3.0 [95% CI 1.08-8.44] p=0.035) and hyperactivity on history (OR=0.2 [95% CI 0.07-0.59] p=0.003) and adenoid-nasopharyngeal ratio (ANR) >0.825 on lateral neck radiography (OR=5.0 [95% CI 1.01-24.37] p=0.048).
One in five children with adenoid or adenotonsillar hypertrophy had pulmonary hypertension with a 3-fold and 5-fold increased odds in those with nasal obstruction on history and ANR >0.825 on lateral neck radiography respectively and an 80% reduced odds in reportedly hyperactive children.
腺样体扁桃体肥大是儿童期的常见病症,其严重并发症肺动脉高压和肺心病具有毁灭性,但当地患病率未知。本研究确定了肯尼亚肯雅塔国家医院腺样体或腺样体扁桃体肥大儿童中肺动脉高压的患病率及相关因素。
这是一项基于医院的横断面调查,对象为12岁以下患有临床和放射学腺样体肥大的儿童,他们在耳鼻喉科(ENT)门诊和普通儿科病房就诊。使用多普勒超声心动图,采用Chemala方程将肺动脉高压定义为平均肺动脉压(mPAP)≥25mmHg。将mPAP≥25mmHg的儿童与mPAP较低的儿童进行比较,并使用多因素逻辑回归分析确定与肺动脉高压相关的临床和放射学因素。
在该研究的123名符合条件的儿童中,27名患有肺动脉高压,患病率为21.9%(95%CI为14.64%-29.27%)。与肺动脉高压相关的独立因素包括鼻塞(OR=3.0[95%CI为1.08-8.44],p=0.035)、既往史中有多动(OR=0.2[95%CI为0.07-0.59],p=0.003)以及侧位颈部X线片显示腺样体-鼻咽比值(ANR)>0.825(OR=5.0[95%CI为1.01-24.37],p=0.048)。
五分之一的腺样体或腺样体扁桃体肥大儿童患有肺动脉高压,既往有鼻塞史的儿童患病几率增加3倍,侧位颈部X线片显示ANR>0.825的儿童患病几率增加5倍,而据报告有多动的儿童患病几率降低80%。